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ABSTRACT 18 
Adeno-associated virus 2 (AAV2) depends for productive replication on the simultaneous 19 
presence of a helper virus such as herpes simplex virus type 1 (HSV-1). At the same time, 20 
AAV2 efficiently blocks the replication of HSV-1, which would eventually limit its own 21 
replication by diminishing the helper virus reservoir. This discrepancy begs the question how 22 
AAV2 and HSV-1 can co-exist in a cell population. Here we show that in co-infected 23 
cultures, AAV2 DNA replication takes place almost exclusively in S/G2 cells, while HSV-1 24 
DNA replication is restricted to G1. Live microscopy revealed that not only wtAAV2 25 
replication but also reporter gene expression from both single-stranded and double-stranded 26 
(self-complementary) recombinant AAV2 vectors preferentially occurs in S/G2 cells, 27 
suggesting that the S/G2 preference is independent of the nature of the viral genome. 28 
Interestingly, however, a substantial proportion of the S/G2 cells transduced by the double-29 
stranded but not the single-stranded recombinant AAV2 vectors progressed through mitosis 30 
in absence of the helper virus. We conclude that cell cycle-dependent AAV2 rep expression 31 
facilitates cell cycle-dependent AAV2 DNA replication, and inhibits HSV-1 DNA replication. 32 
This may limit competition for cellular and viral helper factors, and hence, creates a 33 
biological niche for either virus to replicate.  34 
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IMPORTANCE 35 
Adeno-associated virus 2 (AAV2) differs from most other viruses, as it requires not only a 36 
host cell for replication but also a helper virus such as an adenovirus or a herpes virus. This 37 
situation inevitably leads to competition for cellular resources. AAV2 has been shown to 38 
efficiently inhibit the replication of helper viruses. Here, we present a new facet of the 39 
interaction between AAV2 and one of its helper viruses, herpes simplex virus type 1 (HSV-40 
1). We observed that AAV2 rep gene expression is cell cycle dependent, and gives rise to 41 
distinct time controlled windows for HSV-1 replication. High Rep protein levels in S/G2 42 
phases support AAV2 replication and inhibit HSV-1 replication. Conversely, low Rep protein 43 
levels in G1 permit HSV-1 replication, but are insufficient for AAV2 replication. This allows 44 
both viruses to productively replicate in distinct sets of dividing cells. 45 
KEYWORDS AAV2, HSV-1, helper virus, cell cycle, Rep proteins, biological niche 46 
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INTRODUCTION 47 
Viruses depend on host cell factors for the replication of their genome. As the nucleic acid 48 
metabolites accumulate during the S phase of the cell cycle, many DNA viruses such as 49 
autonomous parvoviruses, adenoviruses, or herpesviruses have evolved mechanisms to 50 
manipulate cell cycle progression and induce S or G2 phase arrest, which allows them to 51 
replicate their genomes in concert with the cellular DNA (1-3). Herpes simplex virus type 1 52 
(HSV-1) is an enveloped human pathogen with a double-stranded DNA genome of 152 kbp 53 
encoding approximately 90 proteins (reviewed in reference (4)). Among those are 7 54 
enzymes, which are essential and sufficient to support HSV-1 DNA replication in cells, and 55 
several accessory proteins, including uracyl DNA glycosylase, alkaline exonuclease, 56 
thymidine kinase, or ribonucleotide reductase, which are homologous to important cellular S 57 
phase proteins. HSV-1 may therefore be less dependent on cellular proteins and a specific 58 
phase of the cell cycle. Indeed, unlike many other DNA viruses HSV-1 has been shown to 59 
replicate well outside of the S phase and to possess mechanisms for actively arresting cells 60 
in G1 and G2 (5-9).  61 
In contrast, adeno-associated virus 2 (AAV2) is a non-pathogenic human parvovirus with a 62 
small, single-stranded DNA genome of 4,680 nucleotides. As for herpes viruses, the AAV2 63 
genome is packed in an icosahedral capsid, albeit without a lipid envelope and smaller in 64 
size than the herpesvirus capsid. The AAV2 genome contains only two clusters of genes, 65 
rep and cap, flanked by inverted terminal repeats (ITRs), which contain the viral origin of 66 
DNA replication and packaging signal. Cap gene expression is controlled by the p40 67 
promoter and gives rise to the capsid proteins VP1, VP2, and VP3 which, due to alternative 68 
start codons, differ in their N-termini (reviewed in reference (10)). In addition, a nested open 69 
reading frame within the cap gene encodes a protein designated assembly-activating 70 
protein, which is believed to be required for AAV2 capsid assembly in the nucleolus (11). 71 
The rep gene cluster encodes four Rep isoforms, Rep40, Rep52, Rep68, and Rep78, due to 72 
transcription from two different promoters, p5 and p19, and alternative splicing at an intron 73 
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near the C-terminus. The multifunctional Rep proteins are involved in diverse processes of 74 
the AAV2 life cycle, including DNA replication, regulation of gene expression, genome 75 
packaging, and site-specific integration (12-17). The functions of the Rep proteins include 76 
site-specific DNA-binding and endonuclease activities (Rep68 and 78), as well as site non-77 
specific ATPase/helicase activity (all Rep isoforms) (18-22). Likely because of its low genetic 78 
complexity, AAV2 depends not only on a cell for productive replication, but also on the 79 
presence of a helper virus, such as HSV-1, adenovirus 2 (AdV2), or human papillomavirus 80 
16 (HPV16) (23-25). In absence of a helper virus, AAV2 enters cells and establishes a latent 81 
infection by maintaining its DNA episomal or inserting it into the host cell genome, 82 
preferentially at a site termed AAVS1 on human chromosome 19 (14, 26-28). The 83 
dependence of AAV2 on a helper virus inevitably leads to competition for cellular resources 84 
and viral factors which are essential for both AAV2 and helper virus replication, such as the 85 
HSV-1 ICP8 protein and the helicase/primase complex (29-31). HSV-1 provides also 86 
accessory proteins, including the ICP0 protein and the viral DNA polymerase (31), and may 87 
condition the cellular environment to promote AAV2 replication, e.g. by interfering with 88 
cellular DNA damage signaling (32) or cell cycle progression (5-9, 33).  89 
AAV2 has been demonstrated to efficiently inhibit the replication of its helper viruses human 90 
adenovirus type 2 from species C (HAdV-C2) (34-36) and HSV-1 (37, 38). For example, the 91 
Rep-mediated inhibition of the protein kinases PKA and PRKX, both members of the cyclic 92 
AMP (cAMP) signal transduction pathway, results in decreased expression of cAMP-93 
responsive genes and contributes to Rep-mediated inhibition of AdV replication (39-42). 94 
Although the mechanism how AAV2 inhibits HSV-1 replication is less well understood, it also 95 
involves the large Rep proteins, in particular the DNA binding and ATPase/helicase activities 96 
of Rep68 and 78 (43). We have previously shown that Rep68 can bind to consensus Rep-97 
binding sites located on the HSV-1 genome, and that the Rep helicase domain is sufficient 98 
to inhibit DNA replication if binding is facilitated (44). Interestingly however, while the 99 
formation of mature HSV-1 replication compartments (RCs) is almost entirely prevented in 100 
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cells that support productive AAV2 replication (38), HSV-1 progeny yield from co-infected 101 
cultures is only approximately 10-fold lower than in cultures infected with HSV-1 alone 102 
(unpublished observation). Because of this observation and the fact that HSV-1 can replicate 103 
well in different phases of the cell cycle, we addressed the following two questions: (i) Do 104 
HSV-1 provided helper functions allow AAV2 to replicate in different phases of the cell cycle 105 
and (ii) do AAV2 and HSV-1 replicate in different sets of cells in co-infected cultures? 106 
The results presented here imply that HSV-1 does not extend its ability to replicate in 107 
different phases of the cell cycle to AAV2. In fact, AAV2 gene expression both in presence 108 
or absence of the helper-virus and AAV2 replication occur almost exclusively in S/G2 cells. 109 
HSV-1 lost its capability to replicate in S/G2 cells in presence of AAV2 rep gene 110 
expression/DNA replication but still replicated in G1.  111 
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RESULTS 112 
For productive infection AAV2 requires a helper virus and a cell in S/G2 phase. We 113 
examined the formation of AAV2 replication compartments (RCs) in HeLa Fucci cells which 114 
express fluorescent ubiquitination-based cell cycle indicators (Fucci) (45). Specifically, HeLa 115 
Fucci cells express green- and red-fluorescent proteins fused to geminin and Cdt1, 116 
respectively. In the G1 phase of the cell cycle, geminin undergoes proteasome-dependent 117 
degradation and the cells appear red. In the S, G2, and M phases of the cell cycle, Cdt1 is 118 
ubiquitinated and degraded; thus, the cells appear green. Cells in early S phase 119 
simultaneously express Cdt1 and geminin and appear orange. In early G1, no fluorescence 120 
marker is expressed. 121 
In the first set of experiments, HeLa Fucci cells were infected with wtHSV-1 alone or co-122 
infected with wtAAV2 and wtHSV-1. After 24 h viral RCs were visualized by confocal laser 123 
scanning microscopy (CLSM) with antibodies specific for the HSV-1 and AAV2 DNA binding 124 
proteins ICP8 and Rep, respectively. In cells infected with HSV-1 alone, we detected HSV-1 125 
RCs both in red fluorescent (G1) and green fluorescent (S/G2) cells (Fig. 1, A and C; ratio 126 
S/G2:G1 = 1.11 +/- 0.36), which is consistent with previous studies showing that HSV-1 can 127 
replicate in G1, S, and G2 phases (5-9). By contrast, AAV2 RCs were identified 128 
predominantly in the nuclei of cells expressing the green fluorescent S/G2 phase marker 129 
geminin (Fig. 1, B and C; ratio S/G2:G1 = 6.65 +/- 1.01). The S/G2:G1 ratios of total mock-130 
infected HeLa Fucci cells (not gated for RCs) were 1.75 +/-0.10 at 0h p.i. and 1.20 +/- 0.05 131 
at 24 h p.i.; the S/G2:G1 ratios were 1.04 +/- 0.02 in total wtHSV-1 infected and 0.93 +/- 0.02 132 
in wtAAV2 and wtHSV-1 co-infected HeLa Fucci cells. The preference of AAV2 to replicate 133 
in the S/G2 phase of the cell cycle was confirmed also by fluorescence in situ hybridization 134 
(FISH) with a probe specific for the AAV2 DNA (Fig. 2A). While no FISH signal was detected 135 
in non-infected cells (top row), in the cultures infected with wtAAV2 alone, fluorescent dots 136 
representing AAV2 genomes were observed in both S/G2 as well as G1 cells (center row). 137 
Co-infection with the helper virus supported the formation of AAV2 RCs, and these were 138 
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 8
found predominantly in the nuclei of S/G2 cells (bottom row and Fig. 2B). Of note, the AAV2 139 
genomes that have been observed in absence of the helper virus (Fig. 2A, center row) were 140 
not visible in the bottom row of Fig. 2A because the laser intensity was strongly reduced for 141 
the acquisition of the brightly fluorescent AAV2 RCs. Taken together, these data show that 142 
efficient AAV2 replication requires not only the presence of a helper virus but also the cell to 143 
be in S/G2 phase of the cell cycle. Therefore, HSV-1 cannot extend its ability to replicate in 144 
different phases of the cell cycle to AAV2. 145 
In co-infected cultures HSV-1 DNA replication is inhibited specifically in S/G2 cells. In 146 
the previous experiments we monitored cell cycle phases and virus replication in non-gated 147 
cells (Fig. 1, A and B; Fig. 2A) and we also determined cell cycle phases of cells "gated" for 148 
viral replication markers (Figs. 1C and 2B). Next, we analyzed virus replication in cells gated 149 
for cell cycle phase. Specifically, HeLa Fucci cells were infected with wtHSV-1 or co-infected 150 
with wtHSV-1 and wtAAV2. After 24 h, cells positive for Cdt1 (G1, red) or geminin (S/G2, 151 
green) were sorted by FACS and equal cell equivalents were analyzed by Southern blot, 152 
Western blot, and qPCR. Consistent with the findings above, the results of these assays 153 
showed that in absence of AAV2, HSV-1 DNA replication was at least as efficient in S/G2 154 
phase as it was in G1 (Fig. 3, A and C), while AAV2 DNA replication in S/G2 was at least 6-155 
fold more efficient than in G1 (Fig. 3, A and D). HSV-1 replication in G1 cells appeared to be 156 
equally efficient in presence or absence of AAV2 (Fig. 3, A and C). Interestingly however, in 157 
presence of AAV2, HSV-1 DNA was no longer detected by Southern blot in S/G2 cells (Fig. 158 
3A), and qPCR revealed an approximately 4-fold reduction of HSV-1 DNA in S/G2 cells 159 
when compared to G1 cells from co-infected cultures and approximately 6-fold reduction 160 
when compared to S/G2 cells from cultures infected with HSV-1 alone (Fig. 3C). As infection 161 
control, HSV-1 ICP0 and AAV2 Rep proteins were detected by Western blot (Fig. 3B). Of 162 
note, the levels of AAV2 DNA appear to directly correlate with the levels of AAV2 Rep 163 
proteins in the different cell cycle phases (Fig. 3, A and B). Cell cycle phases of HeLa Fucci 164 
cells sorted into G1 (Cdt1, red), early S (Cdt1 and geminin, orange), and S/G2 (geminin, 165 
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 9
green) populations by FACS were confirmed by DAPI staining and flow cytometry (not 166 
shown). 167 
These data show that the previously reported AAV2-mediated inhibition of HSV-1 replication 168 
(37, 38) is specific to S/G2 phases of the cell cycle and correlates with efficient AAV2 169 
replication in these cell cycle phases. The next experiment was performed to investigate 170 
whether HSV-1 can replicate in G1 cells despite the presence of AAV2 genomes or simply 171 
because AAV2 genomes are absent from those cells. For this HeLa Fucci cells were co-172 
infected with wtAAV2 and a recombinant HSV-1 that encodes ECFP fused with the HSV-1 173 
ICP4 protein (rHSV-1vECFP-ICP4) and thus facilitates the observation of HSV-1 RCs due to 174 
the binding of the fluorescent ICP4 fusion protein to the replicating HSV-1 DNA in the cell 175 
nucleus (46). After 24 h, the cells were fixed and FISH staining was performed using an AF-176 
647 labeled AAV2 DNA probe. The micrographs shown in Fig. 4 demonstrate that HSV-1 177 
RCs are formed in G1 cells despite the presence of AAV2 genomes. 178 
Cell cycle dependent AAV2 DNA replication is controlled by cell cycle dependent 179 
AAV2 rep expression. In absence of a helper virus, gene expression from replication-180 
defective recombinant AAV2 vectors has previously been shown to occur preferentially in 181 
the S phase of the cell cycle (47, 48). To address the question whether this applies also 182 
when a helper virus is present, we co-infected HeLa Fucci cells with wtHSV-1 and 183 
recombinant AAV2 vectors encoding fluorescent reporter proteins fused in frame with AAV2 184 
Rep (rAAVCFPRep, rAAVYFPRep). The AAV2 p5 promoter used in these vectors for 185 
transcriptional control of reporter gene expression is highly regulated during co-infection; in 186 
particular, its activity is very low in absence of HSV-1. Therefore, we also used a 187 
recombinant AAV2 vector that expresses a reporter gene from the constitutively active 188 
human cytomegalovirus (CMV) IE1 enhancer/promoter (rAAVCFPNeo) to exclude a 189 
potential promoter effect responsible for the observed cell cycle dependent AAV2 DNA 190 
replication/gene expression. Viral gene expression and cell cycle phase was determined by 191 
fluorescence microscopy or flow cytometry. Upon co-infection of HeLa Fucci cells with 192 
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 10
rAAVCFPNeo and wtHSV-1, the majority of the cyan-fluorescent cells was indeed in S/G2 193 
phases and approximately 10% in G1 and 10% in early S (Fig. 5, A and B). A similar 194 
distribution was observed upon co-infection of HeLa Fucci cells with rAAVCFPRep and 195 
wtHSV-1: approximately 81% of the AAV2 transduced (ECFP-positive) cells were in S/G2 196 
phases, while only 19% were in G1, as determined by flow cytometry (Table 1). The 197 
inefficient AAV2 gene expression in G1 was observed also in other cell lines, including 198 
AT22, HCT116, and NHF (Table 1). For example, in AT22 fibroblast cultures co-infected with 199 
rAAVYFPRep and wtHSV-1, more than 80% of AAV2-transduced (EYFP-positive) cells were 200 
in S or G2 phases, while only approximately 16% of these cells were in G1 (Table 1), 201 
although the majority (approximately 60%) of the non-gated cells in the culture was in G1 202 
phase (not shown). Therefore, HSV-1 helper functions appear to support neither AAV2 203 
replication nor AAV2 (rep) gene expression in G1 cells, independent of the promoter, p5 or 204 
CMV. Inefficient AAV2 gene expression in G1, and consequently low levels of AAV2 Rep 205 
proteins (as indeed observed in Fig. 3B) are likely responsible for the inefficient AAV2 206 
replication and the inefficient inhibition of HSV-1 replication in that cell cycle phase, as AAV2 207 
Rep proteins are known to be essential for AAV2 replication and responsible also for the 208 
inhibition of HSV-1 replication (43, 49). 209 
Next, we addressed the question whether in co-infected cultures HSV-1 replication is 210 
allowed in the G1 cells and inhibited in the S/G2 cells, because AAV2 rep is expressed 211 
efficiently only in the S/G2 but not G1 cells. For this, we used a recombinant HSV-1 that 212 
encodes the VP16 protein fused with EYFP (rHSV48EYFP; reference (50)). EYFP-VP16 213 
accumulates on the HSV-1 DNA, and hence is a marker for HSV-1 RCs (50, 51). To 214 
simultaneously visualize AAV2 Rep, we used rAAVCFPRep which encodes an ECFP-Rep 215 
fusion protein from the viral p5 promoter, and allows not only cell cycle-dependent 216 
replication of the viral genome in presence of a helper virus but also monitoring AAV2 RCs 217 
via interaction of the fluorescent Rep fusion protein with the replicating viral DNA (reference 218 
(31); see also Movie S1). As expected, in cultures co-infected with rHSV48EYFP and 219 
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 11
rAAVCFPRep, HSV-1 RCs and AAV2 RCs were not co-detected in individual cells (Fig. 5C, 220 
left). However, in cells co-infected with rHSV48EYFP and rAAVCFPNeo, which encodes 221 
ECFP but no AAV2 Rep proteins, yellow fluorescent HSV RCs were readily detected both in 222 
ECFP-positive and in ECFP-negative cells (Fig. 5C, right). By using an epifluorescence 223 
microscope, cells positive for yellow fluorescent HSV-1 RCs were examined for ECFP 224 
fluorescence (Fig. 5D). In the rHSV48EYFP and rAAVCFPRep co-infected cultures, less 225 
than 5% of the cells containing HSV-1 RCs were ECFP-Rep positive. In contrast, in the 226 
rHSV48EYFP and rAAVCFPNeo co-infected cultures, approximately 50% of the cells 227 
containing HSV-1 RCs were positive also for the AAV2 marker ECFP. Since rAAVCFPNeo 228 
transduction was observed predominantly in S/G2 phases of the cell cycle (Fig. 5, A and B), 229 
these data suggest that AAV2 infection or non-replicating AAV2 DNA per se is not sufficient 230 
to inhibit HSV-1 replication in S/G2 phases but that rep expression is required. This is 231 
supported also by a previous finding that UV-inactivated wtAAV2 genomes, which do not 232 
express any AAV2 genes, did not inhibit HSV-1 replication (43). In conclusion, cell cycle-233 
dependent AAV2 rep expression seems to be responsible for the observed negative 234 
correlation between HSV-1 and AAV2 replication efficiencies in different phases of the cell 235 
cycle. Low Rep levels in G1 allow HSV-1 but not AAV2 to replicate, while high Rep levels in 236 
S/G2 support AAV2 replication and block HSV-1 replication.  237 
Both single-stranded and double-stranded AAV2 vectors predominantly transduce 238 
cells in S/G2 phases, independent of the presence or absence of a helper virus. We 239 
used two different approaches to test whether the single-stranded nature of the AAV2 DNA 240 
plays a role in the cell cycle-dependent AAV2 gene expression: transfection of plasmid 241 
cloned AAV2 genomes and infection with self-complementary (sc) recombinant AAV2 242 
vectors, which can form a double-stranded DNA by self-annealing and therefore do not 243 
depend on second-strand synthesis for viral gene expression. Specifically, HeLa Fucci cells 244 
were transfected with plasmids containing rep-positive (pAAVCFPRep) or rep-negative 245 
(pAAVCFPp5) recombinant AAV2 genomes and, 4 h later, mock-infected or infected with 246 
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wtHSV-1. After 24 h, the cells were examined by CLSM. The results are shown in Fig. 6 and 247 
can be summarized as follows: ECFP-fluorescent AAV2 RCs were readily detected both in 248 
G1 and in S/G2 cells of cultures transfected with pAAVCFPRep and infected with the helper 249 
virus (Fig. 6A). In presence of HSV-1, ECFP-fluorescence was also detected both in G1 and 250 
in S/G2 cells of cultures transfected with pAAVCFPp5, but in these cells ECFP-fluorescence 251 
was diffuse and AAV2 RCs were not observed because of the absence of rep (Fig. 6B). No 252 
ECFP-fluorescence was observed in absence of HSV-1, as both plasmids use the helper 253 
virus-dependent AAV2 p5 promoter for transgene expression (not shown). 254 
To confirm that HSV-1 supported AAV2 DNA replication can indeed take place in G1 when 255 
the template is a circular double-stranded DNA, HeLa Fucci cells were transfected with 256 
pAAVCFPRep and, 4 h later, mock-infected or infected with wtHSV-1. After 24 h, episomal 257 
DNA was prepared from G1 and S/G2 cells according to the method described by Hirt (52) 258 
and subjected to qPCR with primers specific for rep. The graph in Fig. 6C shows that the 259 
relative AAV2 DNA content in G1 cells is 80% larger in presence of the helper virus, 260 
presumably because of DNA replication. We then tested whether HSV-1 DNA replication 261 
was blocked also in G1 cells, when rep is expressed from a plasmid-cloned recombinant 262 
AAV2 genome. The graph in Fig. 6D shows that this is clearly the case. The HSV-1 DNA 263 
content of ECFP (AAV2) and Cdt1 (G1, red) double-positive HeLa Fucci cells transfected 264 
with pAAVCFPRep prior to HSV-1 infection was reduced by more than 60% compared to 265 
that of cells transfected with rep-negative pAAVCFPp5 plasmid DNA prior to infection with 266 
the helper virus. In summary these data show that AAV2 (rep) gene expression, AAV2 267 
genome replication, and inhibition of HSV-1 replication can take place in G1 cells, when the 268 
AAV2 genome is provided as a circular double-stranded rather than a linear single-stranded 269 
DNA template.  270 
These data suggest that AAV2 second-strand synthesis may be the limiting factor for 271 
efficient AAV2 gene expression/genome replication in G1 and accordingly, one would expect 272 
that self-complementary AAV2 (scAAV2) vectors would support gene expression in that cell 273 
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cycle phase. To investigate this possibility, we infected HeLa Fucci cells with scAAVCFP in 274 
presence or absence of the helper virus and monitored reporter gene expression (ECFP) 275 
and cell cycle phase from 2-20 h after infection (Fig. 7). Indeed, at 20 h after infection, many 276 
transgene-positive G1 cells (purple) were observed in scAAVCFP infected cultures in 277 
absence of the helper virus (Fig. 7A, left). However, tracking of individual cells over time 278 
revealed that the transgene positive G1 cells observed at 20 h after infection originated from 279 
cells that became transgene positive in S/G2 and then went through mitosis (arrows in Fig. 280 
7A, right panels; see also Movie S2). Occasionally, cells turned transgene positive in G1 281 
phase (not shown). Co-infection with wtHSV-1 largely prevented the generation of transgene 282 
positive G1 cells (Fig. 7A), presumably because of an HSV-1 mediated G2 arrest (5, 33). As 283 
expected from the previous data, the vast majority of the cells infected with the single-284 
stranded AAV2 vector (rAAVCFPNeo) turned transgene positive in S/G2 phase and did not 285 
progress through mitosis, independent of the presence or absence of the helper virus (Fig. 286 
7A; see also Movie S3). Also as expected from the previous data, transgene positive G1 287 
cells were occasionally observed also in rAAVCFPNeo infected cultures in absence of the 288 
helper virus. These cells often but not always originated from transgene positive S/G2 cells 289 
that progressed to G1, sometimes without division (Fig. 7A). To quantify the observations 290 
from live microscopy, we tracked and counted cells over time from the moment AAV2 vector-291 
encoded ECFP-fluorescence became visible. The graph in Fig. 7B shows that more than 292 
90% of the cells turned ECFP-positive in S/G2, independent of the genome structure, single-293 
stranded or double-stranded (self-complementary), or the presence or absence of the helper 294 
virus. However, in absence of wtHSV-1, ECFP-fluorescent S/G2 cells progressed through 295 
mitosis to G1 phase with a significantly higher frequency when infected with scAAVCFP than 296 
with rAAVCFPNeo (Fig. 7C). 297 
Overall, we conclude that (i) HSV-1 is not capable of extending its ability to replicate in all 298 
phases of the cell cycle to AAV2. (ii) Cell cycle dependent AAV2 DNA replication and 299 
inhibition of HSV-1 DNA replication is due to cell cycle-dependent AAV2 rep expression. (iii) 300 
 o
n
 June 1, 2017 by UZH Hauptbibliothek / Zentralbibliothek Zuerich
http://jvi.asm.org/
D
ow
nloaded from
 
 14
Second-strand synthesis is likely not responsible for the cell cycle preference because both 301 
single-stranded and double-stranded linear AAV2 genomes preferentially transduce cells in 302 
S/G2 phases.  303 
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DISCUSSION 304 
In this study, we addressed the question how AAV2 and HSV-1 coordinate their replication 305 
programs. For this we used a fluorescence microscopy approach scoring different cell cycle 306 
stages and viral RCs on a single cell level, and combined the results with biochemical virus 307 
replication measurements in isolated cells at the G1 and S/G2 stages. We find that AAV2 308 
replication occurs predominantly in S/G2 phases. Also, AAV2 gene expression was 309 
restricted to S/G2 cells both in presence or absence of the helper virus. HSV-1 replication 310 
was in turn restricted to G1 cells in co-infected cultures, while it replicated efficiently both in 311 
G1 and in S/G2 cells in absence of AAV2 (for an overview see Tables 2 and 3). On the other 312 
hand, HSV-1 RCs were readily detected in S/G2 cells transduced with a rep-negative 313 
recombinant AAV2 vector. Therefore, as Rep proteins are essential for AAV2 replication and 314 
have been found to be at least partially responsible for the AAV2 mediated inhibition of HSV-315 
1 replication (38, 43, 44), we conclude that cell cycle dependent AAV2 rep expression is 316 
responsible for the observed restriction of AAV2 replication to S/G2 cells and HSV-1 317 
replication to G1 cells. 318 
We have previously shown that the AAV2 Rep68/78 proteins, in particular the combined 319 
DNA-binding and the ATPase/helicase activities can block HSV-1 DNA replication on the 320 
level of DNA synthesis, even in the absence of AAV2 DNA. We also demonstrated that 321 
AAV2 Rep68 can bind to consensus Rep-binding sites on the HSV-1 genome, and that the 322 
helicase activity can block the replication of any DNA if binding is facilitated (44). However, 323 
the conclusion from the present study that the inhibition of HSV-1 replication is limited to 324 
S/G2 cells because AAV2 rep is expressed efficiently only in that phase inevitably begs for 325 
the question of what controls the cell cycle dependent expression of rep. Recombinant AAV2 326 
vectors have been reported to transduce cells predominantly in S phase in absence of a 327 
helper virus (47, 48). Our finding that HSV-1 provided helper functions do not support AAV2 328 
replication and gene expression in G1, although HSV-1 itself can replicate in G1 and S/G2 329 
and although the HSV-1 protein ICP0 strongly trans-activates AAV2 rep expression, 330 
 o
n
 June 1, 2017 by UZH Hauptbibliothek / Zentralbibliothek Zuerich
http://jvi.asm.org/
D
ow
nloaded from
 
 16
indicates that a step prior to AAV2 transcription may be blocked. One obvious such step is 331 
second-strand synthesis. For example, cellular proteins involved in second-strand synthesis 332 
such as polymerases or co-factors may not be available at sufficient concentrations in G1. 333 
Likewise, factors that block second-strand synthesis such as DNA damage repair proteins 334 
may be abundant or activated in G1 but not in S/G2. We demonstrate that AAV2 335 
transcription and replication is efficient in S/G2 as well as in G1 cells when the template is a 336 
circular double-stranded rather than a linear single-stranded DNA template, indicating that 337 
cell cycle-dependent rep expression may indeed be due to cell cycle-dependent second-338 
strand synthesis. However, the circular versus linear state of the two template DNAs as well 339 
as the different means of delivery, transfection versus infection, may also affect transcription 340 
in a cell cycle-dependent manner, possibilities that were further explored by using scAAV2 341 
vectors. If inefficient second-strand synthesis in G1 was solely responsible for the observed 342 
cell cycle-dependent AAV2 replication and gene expression one would expect that scAAV2 343 
vectors, which can form a double-stranded DNA by self-annealing and therefore do not 344 
depend on second-strand synthesis for gene expression, can transduce both G1 and S/G2 345 
cells efficiently. Indeed, in scAAV2 vector transduced cell cultures we observed a 346 
considerable proportion of AAV2 transgene-positive G1 cells in absence of the helper virus. 347 
But interestingly, high-throughput multi-channel time-laps microscopy of cell cycle 348 
progression and viral gene expression showed that the majority of the scAAV2 transduced 349 
G1 cells originated from scAAV2 transduced S/G2 cells that progressed through mitosis, an 350 
event that was observed at a significantly lower rate upon infection with the single-stranded 351 
rAAV2 vector (for an overview see Table 3). We hypothesize that rAAV2 vectors, similar to 352 
wtAAV2 (53), can induce a cell cycle arrest more efficiently than the scAAV2 vectors 353 
because of the single-stranded versus double-stranded nature of the genome. In presence 354 
of the helper virus, neither single-stranded nor double-stranded AAV2 vector-transduced 355 
cells progressed through mitosis, presumably because of an HSV-1 induced G2 arrest (33). 356 
This hypothesis is supported by the finding that co-infection with an ICP0 deletion mutant of 357 
HSV-1, which is replication-competent but does not induce a cell cycle arrest in G2 (33), 358 
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allowed scAAV2 vector transduced G2 cells but not rAAV2 vector transduced G2 cells to 359 
progress through mitosis (data not shown).  360 
The findings in this study may have important implications for AAV2-mediated gene therapy. 361 
Both single-stranded and double-stranded AAV2 vectors depend on cells in S/G2 phase for 362 
efficient gene expression, which in fact may contribute to their low transduction efficiency, at 363 
least in post-mitotic cells. However, when the target cells are mitotically active, the double-364 
stranded AAV2 vectors may be preferred as they allow the cells to go through mitosis while 365 
the single-stranded AAV2 vectors do not. On the other hand, scAAV2 vectors have been 366 
shown to induce a more robust innate immune response in mouse liver than rAAV2 vectors 367 
(54). In any event, it would be interesting to compare the effect of scAAV2 and rAAV2 368 
vectors on specific factors involved in cell cycle regulation, including p53, retinoblastoma 369 
protein, cyclin dependent kinases (CDK), and CDK inhibitors. 370 
The observation that both single-stranded and double-stranded AAV2 vectors transduce 371 
cells predominantly in S/G2 phases argues against second-strand synthesis as the 372 
mechanism responsible for the cell-cycle dependent AAV2 gene expression/DNA replication 373 
and inhibition of HSV-1 DNA replication. Nevertheless, the preference of AAV2 to transduce 374 
cells in S/G2 phases of the cell cycle may likely be orchestrated by cellular factors other than 375 
those involved in second-strand synthesis. In fact, many different cellular proteins are 376 
recruited to AAV2 genomes (32, 55-57). Among those, the DNA damage response (DDR) 377 
proteins represent a very prominent group and may differentially affect specific phases in 378 
AAV2 genome processing, such as circularization, replication and transcription. DNA 379 
damage response is closely linked with the cell cycle through checkpoint proteins. Moreover, 380 
there is increasing evidence that CDKs, which are the master regulators of cell cycle 381 
progression, have a role also in regulation of the DNA damage repair (for reviews see (58-382 
60), thereby coordinating DNA repair and cell cycle progression. For example, it has been 383 
shown that CDK1 activity regulates the choice between different double-strand break (DSB) 384 
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repair pathways, homologous recombination (HR) and non homologous end joining (NHEJ). 385 
In G1, CDK1 activity is low and NHEJ is used while in S/G2/M phases CDK1 activity is high 386 
and HR is employed (61, 62). CDK1 activity stimulates HR by promoting generation of the 3’ 387 
single-stranded DNA ends which are necessary for HR and inhibitory for NHEJ (61-63). It 388 
has also been shown that CDK activity is essential for later steps in HR, specifically in the 389 
recruitment of Rad51 (64). Functional roles in DNA damage repair pathways have been 390 
demonstrated also for other CDKs in complex with cyclins (for a review see (65)). 391 
The licensing factor that allows AAV2 gene expression/DNA replication in S/G2 phase or the 392 
inhibitor that blocks it in G1 remains to be identified. Nevertheless, the “partitioning” of the 393 
host cell population between the two different viruses is a novel concept of viral adaptation 394 
and a fascinating strategy to minimize competition allowing both, AAV2 and HSV-1 to 395 
productively replicate, although in distinct sets of cells.  396 
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METHODS 397 
Cells. Normal human fibroblasts (NHF) were obtained from X.O. Breakefield, Massachusetts 398 
General Hospital, Charlestown, MA, USA. HeLa Fucci cells were a gift from B. Kraus, 399 
University of Regensburg, Regensburg, Germany; these cells encode cell cycle specific 400 
proteins fused with red fluorescent (Cdt1, G1) or green fluorescent (geminin, S/G2) fusion 401 
proteins (45). HCT116 cells were provided by E. Hendrickson, University of Minnesota, 402 
Minneapolis, MN, USA. NHF, HeLa Fucci, HCT116 and HeLa (ATCC) cells were cultured in 403 
Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum 404 
(FBS), 100 U/ml penicillin G, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin B (1% 405 
AB). AT22 IJE-T yZ5 cells (kindly provided by Y. Shiloh, Tel Aviv University, Tel Aviv, Israel) 406 
were cultured in DMEM supplemented with 10% FBS, 1% AB, and 100 μg/ml hygromycin B. 407 
Vero cells (ECACC) and 293T cells (kindly provided by J. Neidhardt, University of Zurich, 408 
Zurich, Switzerland) were grown in DMEM supplemented with 10% FBS and 1% AB. All 409 
cells were maintained at 37°C in a 95% air–5% CO2 atmosphere. For all infection 410 
experiments, virus was allowed to adsorb for 30 min at 4oC before the temperature was 411 
shifted to 37oC for 1 h. The cells were then washed with phosphate-buffered saline (PBS) 412 
and incubated with DMEM containing 2% FBS and 1% AB at 37°C for the indicated times 413 
after infection. 414 
Plasmids and viruses. Wild-type (wt) HSV-1 strain F was provided by B. Roizman 415 
(University of Chicago, Chicago, IL). Recombinant HSV-1 encoding ICP4 fused with ECFP 416 
(rHSV-1vECFP-ICP4; reference (46)) was obtained from R.D. Everett, University of 417 
Glasgow, Glasgow, UK. Recombinant HSV-1 rHSV48EYFP encoding the VP16 protein 418 
fused with EYFP was described previously (50). Wt and recombinant HSV-1 were grown 419 
and titrated on Vero cells. Plasmid pAAVtCR which contains a recombinant AAV2 genome 420 
that lacks the cap gene and encodes unmodified Rep40/52 under control of the p19 421 
promoter and Rep68/78 fused at the N terminus with the fluorescent protein mCherry (31)  422 
under control of the p5 promoter, was obtained from A. Salvetti (University of Lyon, Lyon, 423 
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France). Plasmids containing recombinant AAV2 genomes pAAVCFPRep or pAAVYFPRep 424 
were constructed by replacing the mCherry coding sequence in the pAAVtCR plasmid with 425 
ECFP or EYFP coding sequences, respectively, as follows: pAAVtCR was treated first with 426 
BsrGI and then partially with BamHI, and the 5169 bp fragment was ligated with the 738 bp 427 
BsrGI-BamHI fragment containing the ECFP or EYFP coding sequences from pECFP-N2 or 428 
pEYFP-N2 (Clontech), respectively. Plasmid pAAVCFPp5, which encodes ECFP from the 429 
AAV2 p5 promoter was constructed by replacing the 1885 bp BsrGI-SwaI fragment of 430 
pAAVCFPRep, which contains the AAV2 Rep coding sequence, with the BsrG1-SwaI 431 
adaptor oligonucleotide 5’GTACAAGATCGATATTT3’. The recombinant AAV2 genome 432 
rAAVCFPNeo was constructed by replacing the EGFP coding sequence in plasmid 433 
pAAVGFP (provided by M. Linden, King's College London School of Medicine, London, UK) 434 
with the ECFP coding sequence as follows: pECFP-N2 was treated with PstI and NotI, and 435 
the 768 bp fragment was ligated with the 6417 bp PstI-NotI fragment of pAAVGFP. 436 
Transgene expression from pAAVCFPNeo is controlled by the human cytomegalovirus IE1 437 
(CMV) enhancer/promoter. Plasmid pscAAVCFP, which encodes the self-complementary 438 
recombinant AAV2 genome scAAVCFP, was constructed by replacing the EGFP coding 439 
sequence in pscAAVeGFP (kindly provided by J. Neidhardt, University of Zurich, 440 
Switzerland) with the ECFP coding sequence. Specifically, a DNA fragment containing the 441 
CMV enhancer/promoter-ECFP coding sequence was amplified by PCR from plasmid 442 
pCMVeCFP-PolyA (unpublished material) using forward (5'-443 
AAGATATCACTAGTTAGTTATTAATAGTAATCAATTACG-3') and reverse (5'-444 
CCGGTACCA TGCAGTGAAAAAAATGC-3') primers (PCR conditions: 30 sec 98oC, 35x (10 445 
sec 98oC, 45 sec 58oC, 60 sec 72oC), 10 min 72oC), digested with SpeI and NotI, and ligated 446 
between the SpeI and NotI sites of pscAAVeGFP. Recombinant AAV2 stocks were 447 
produced by transient transfection of 293T cells with pDG (66) and either pAAVCFPRep, 448 
pAAVYFPRep, pAAVCFPNeo, or pscAAVCFP. Virus stocks were purified by Iodixanol 449 
gradient, and titers were determined as described elsewhere (67). WtAAV2 was grown and 450 
titrated as described previously (68). 451 
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Antibodies. The following primary antibodies were used: anti-actin (Santa Cruz 452 
Biotechnology SC-10731; dilution for Western blotting [WB], 1:10,000), anti-ICP8 (Abcam 453 
Ab-20193; dilution for WB, 1:1,000; dilution for immunofluorescence [IF] assay, 1:200), anti-454 
AAV2 Rep (Fitzgerald Industries 10R-A111A; dilution for WB, 1:200; dilution for IF 1:50), 455 
anti-ICP0 (ab6513; dilution for WB, 1:2,000). The following secondary antibodies were used: 456 
rabbit anti-mouse IgG-horseradish peroxidase (HRP; Sigma A9044; dilution, 1:10,000), goat 457 
anti-rabbit IgG-HRP (Sigma A6154; dilution, 1:10,000), goat anti-mouse IgG (H+L)-Alexa 458 
Fluor 405 (AF405; Molecular Probes A31556; dilution, 1:500). 459 
Fluorescence-activated cell sorting (FACS) followed by Western blot, Southern blot, 460 
or quantitative PCR. For the experiments shown in Fig. 3, a total of 5x106 HeLa Fucci cells 461 
were seeded into 10-cm tissue culture plates and 24 h later mock-infected, infected with 462 
wtAAV2 (MOI = 8000 genome containing particles per cell) or wtHSV-1 (MOI 3), or co-463 
infected with wtAAV2 (MOI 8000) and wtHSV-1 (MOI 3). After 24 h, cells positive for Cdt1 464 
(G1, red) or geminin (S/G2, green) were sorted using a FACSAria III sorter (BD Biosciences) 465 
and prepared for Western analysis, Southern blot or quantitative (q)PCR. For Western blot 466 
analysis, cells were trypsinized, washed once with PBS, resuspended in 1× loading buffer 467 
(4% SDS, 10% β-mercaptoethanol, 20% glycerol, 0.005% bromphenol blue, 0.125 M Tris-468 
HCl, pH 6.8), and boiled for 10 min. Cell lysates were separated, on 10% SDS-469 
polyacrylamide gels and transferred to Protran nitrocellulose membranes (Whatman, 470 
Bottmingen, Switzerland). The membranes were blocked with PBS-T (PBS containing 0.3% 471 
Tween 20) supplemented with 5% nonfat dry milk for 1 h at room temperature (RT). 472 
Incubation with antibodies was carried out with PBS-T supplemented with 2.5% nonfat dry 473 
milk. Primary antibodies were incubated overnight at 4°C, while secondary antibodies were 474 
incubated for 1 h at RT. Membranes were washed three times with PBS-T for 10 min after 475 
each antibody incubation step. HRP-conjugated secondary antibodies were detected with 476 
ECL detection reagent (ECL WB blotting systems; GE Healthcare, Zurich, Switzerland). The 477 
membranes were exposed to chemiluminescence detection films (Roche Diagnostics, 478 
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Rotkreuz, Switzerland). Detection of anti-actin served as a loading control for the lysate. For 479 
Southern blot analysis, extrachromosomal DNA was extracted according to a protocol 480 
described by Hirt (52). The DNA was separated on 1% agarose gels and transferred to nylon 481 
membranes (Amersham Hybond-N+ RPN119B). Hybridization with a digoxigenin (DIG)-482 
labeled probe specific for the AAV2 Rep78- or the HSV-1 UL35-coding sequences, and 483 
subsequent detection by an anti-DIG antibody conjugated with alkaline phosphatase and 484 
activation with the chemiluminescence substrate CDP Star was performed according to the 485 
manufacturer's protocol (Roche, Mannheim, Germany). The DIG-labeled probe was 486 
produced with the PCR DIG probe synthesis kit (Roche). For qPCR, total DNA was isolated 487 
using the DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the 488 
manufacturer's protocol. Viral DNA content was quantified by qPCR using the cellular TERT 489 
gene as endogenous control (Applied Biosystems, Fostercity, CA, USA) and primers and 490 
TaqMan probe specific for the AAV2 Rep78-coding sequence (fw: 491 
5’ATTGACGGAACTCAACGAC3’; rev: 5’CCTCAACCACGTCCTTT3’; TaqMan probe: 492 
5’CATGATCCAGACGGCGGGTGA3’) or primers specific for the HSV-1 UL42 gene (fw: 493 
5’CCCTCAAGTTCTTCTTCCTCACG3’; rev: 5’GGAGTCCTGGCTGTCTGTTG3’) and SYBR 494 
green (Applied Biosystems, Fostercity, CA, USA). AAV2 sequences were amplified at the 495 
following conditions: 2 min 50oC, 15 min 95oC, 40x (15 sec 94oC, 30 sec 56oC, 15 sec 72oC). 496 
HSV-1 sequences were amplified at the following conditions: 3 min 95oC, 39x (15 sec 95oC, 497 
60 sec 45oC), 10 sec 95oC, 5 sec 65oC, 5 sec 95oC. For the experiments shown in Fig. 7 C 498 
and D, 1.5x106 HeLa Fucci cells in 6 cm tissue culture plates were transfected with 0.5 μg of 499 
either pAAVCFPRep or pAAVCFPp5 using Lipofectamine LTX as described by the 500 
manufacturer (Life Technologies) and, 4 h later, mock-infected or infected with wtHSV-1 501 
(MOI 2) as described in the legend. After 24 h cells positive for the G1 marker Cdt1 (red), or 502 
double-positive for the G1 marker and either CFP-Rep or CFP were sorted using a 503 
FACSAria III sorter (BD Biosciences). Then, Hirt DNA or total DNA was prepared from the 504 
sorted cell populations. To determine the AAV2 DNA content, Hirt DNA was incubated with 505 
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DpnI prior to the qPCR reaction in order to degrade the transfected input plasmid DNA 506 
isolated from E.coli. To determine the HSV-1 DNA content, total DNA was used for qPCR. 507 
Microscopy. For microscopy HeLa or HeLa Fucci cells were seeded onto coverslips (12-508 
mm diameter; Glaswarenfabrik Karl Hecht GmbH & Co. KG, Sondheim, Germany) in 24-well 509 
tissue culture plates (5×104 cells per well) or, specifically for epifluorescence live cell 510 
microscopy, directly into 96-well tissue culture plates (104 cells per well) (see also (69). The 511 
next day, the cells were infected as indicated in the results section and the Figure legends. 512 
For the experiments shown in Fig. 6, the cells were transfected with 0.5 μg of either 513 
pAAVCFPRep or pAAVCFPp5 4 h prior to infection. For live cell microscopy of AAV2 gene 514 
expression/replication and cell cycle progression (Fig. 5A; Fig. 7A; Movies S1-3), images 515 
were acquired every 30 min from 2 to 20 h after infection by automated multi-site multi-516 
channel live epifluorescence microscopy in a time-lapse mode (37° C, 5% CO2, humidified) 517 
using ImageXpress Micro XL (Molecular Devices) and fluorescence filters (Semrock) for 518 
ECFP (AAV2), GFP (G2 phase) and TRITC (G1 phase) (69, 70); images were processed by 519 
using the Fiji software (71). For standard fluorescence microscopy or CSLM, the cells were 520 
washed once with cold PBS at 24 h after infection and then fixed with 3.7% 521 
paraformaldehyde in PBS for 10 min at RT. The fixation process was stopped by incubation 522 
with 0.1 M glycine for 10 min at RT and washing twice with cold PBS. For 523 
immunofluorescence analysis (Fig. 1, A and B), the cells were permeabilized by treatment 524 
with pre-cooled (−20°C) acetone for 2 min followed by 3 washing steps with PBS. The cells 525 
were blocked for 30 min with 3% bovine serum albumin (BSA) in PBS. For staining, the cells 526 
were incubated with antibodies diluted in PBS-BSA (3%) in a humidified chamber at RT in 527 
the dark. The coverslips were placed on droplets (40 μl) of primary antibody solution. After 528 
incubation for 1 h, the cells were washed three times with PBS and once with H2O. All 529 
coverslips (with and without antibody staining) were embedded in Glycergel 530 
(DakoCytomation, Carpinteria, CA) containing DABCO (26 mg/ml; Fluka, Sigma-Aldrich 531 
Chemie GmbH, Munich, Germany), and cells were observed using a confocal laser scanning 532 
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microscope (CLSM; Leica TCS SP2 AOBS; Leica Microsystems, Wetzlar, Germany; Fig. 1, 533 
A and B; Fig. 6A and B), an automated epifluorescence microscope using ImageXpress 534 
Micro XL (Molecular Devices; Fig. 5A), or a standard fluorescence microscope (Axio 535 
Observer inverted microscope, Zeiss AG, Germany, Fig. 5C). To prevent cross talk between 536 
the channels for the different fluorochromes, all channels were recorded separately and 537 
fluorochromes with longer wavelengths were recorded first.  538 
Flow cytometry. HCT116, AT22, NHF, or HeLa Fucci cells were seeded into wells of a 12-539 
well tissue culture plate (105 cells per well) and 24 h later, co-infected with wtHSV-1 (MOI 540 
1.5 for AT22 cells; MOI 3 for all other cell lines) and either rAAVCFPRep or rAAVYFPRep 541 
(MOI 1000 for HeLa Fucci cells; MOI 4000 for all other cell lines) as indicated in Table 1. All 542 
cells were incubated at 37°C/5% CO2 in DMEM supplemented with 2% FBS and 1% AB. 543 
After 20-24 h, the cells were trypsinized, washed once with PBS, centrifuged for 10 min at 544 
1000 g and resuspended in 1 ml PBS.  The cells were fixed by addition of 2.5 ml EtOH and 545 
incubation overnight at -20°C. To determine the cell cycle phases in HCT116, NHF and 546 
AT22 cells, DNA was stained for 30 min with DAPI (4′,6′-diamidino-2-phenylindole; 1µg/ml in 547 
PBS containing 0.1% Triton-X100) or propidium iodide (PI; 50µg/ml in PBS containing 0.1% 548 
Triton-X100 and 0.1mg/ml RNase A) as indicated in Table 1. A minimum of 40,000 events 549 
were scored for each sample using a Gallios Flow Cytometer (Beckman Coulter), and data 550 
was analyzed using Kaluza® Flow Analysis Software 1.3 (Beckman Coulter). 551 
Fluorescence in situ hybridization (FISH). FISH was performed essentially as described 552 
in Lux et al. (68). Briefly, an approximately 3.9 kb DNA fragment containing the AAV2 553 
genome without the inverted terminal repeats was amplified by PCR from plasmid pDG (66) 554 
using forward (5'-CGGGGTTTTACGAGATTGTG-3') and reverse (5'-555 
GGCTCTGAATACACGCCATT-3') primers and the following conditions: 30 sec 95oC, 35x 556 
(10 sec 98oC, 15 sec 58oC, 75 sec 72oC), 10 min 72oC. Then the PCR product was digested 557 
with DpnI to cut the residual template DNA and purified with Pure Link PCR purification kit 558 
(Qiagen). The DNA fragment was labeled with 5-(3-aminoallyl)dUTP by nick-translation, and 559 
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the incorporated dUTPs were labeled with the amino-reactive Alexa Fluor 647 dye using the 560 
ARES DNA labeling kit (Molecular Probes) according to the manufacturer's protocol. HeLa 561 
Fucci cells were plated on glass coverslips in 24 well plates at a density of 1.4x105 cells per 562 
well and 24 h later mock-infected, infected with wtAAV2 (MOI 4000), or co-infected with 563 
wtAAV2 (MOI 4000) and either wtHSV-1 (MOI 3) or rHSV-1vECFP-ICP4 (MOI 3). At 24 h 564 
after infection, the cells were washed with PBS, fixed for 30 min at RT with 2% PFA (in PBS) 565 
and then washed again with PBS. Then the cells were quenched for 10 min with 50 mM 566 
NH4Cl (in PBS), washed with PBS, permeabilized for 10 min with 0.2% Triton-X100 (in PBS), 567 
blocked for 10 min with 0.2% gelatin (in PBS), and washed again with PBS. The 568 
hybridization solution (20 µl per coverslip) containing 1 ng/µl of the labeled DNA probe, 50% 569 
formamide, 7.3% dextran sulfate, 15 ng/µl salmon sperm DNA and 0.74 x SSC was 570 
denatured for 3 min at 95oC and shock cooled on ice. The coverslips with the fixed and 571 
permeabilized cells facing down were placed on a drop (20 µl) of the denatured hybridization 572 
solution and incubated over night at 37oC in a humidified chamber. (Of note, the cells were 573 
not denatured as the AAV2 genome is a single-stranded DNA). The next day, the coverslips 574 
were washed 3 times with 2 x SSC at 37oC, three times with 0.1 x SSC at 60oC, and twice 575 
with PBS at RT. Then the cells were embedded in ProLong Anti-Fade Mountant (Molecular 576 
Probes) and imaged by confocal laser scanning microscopy (CLSM, Leica SP8; Leica 577 
Microsystems, Wetzlar, Germany). 578 
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FIGURE LEGENDS 798 
FIG 1 Co-detection of cell cycle phase and viral replication compartments. (A and B) HeLa 799 
Fucci cells were infected with wtHSV-1 (MOI 3) or co-infected with wtAAV2 (MOI 4000) and 800 
wtHSV-1 (MOI 3). After 24 h, the cells were fixed and processed for immunofluorescence 801 
analysis and CLSM. (A) HSV-1 replication compartments (RCs) were visualized with a 802 
primary antibody specific for the HSV-1 major DNA binding protein ICP8 and an AF405-803 
labeled secondary antibody (blue). (B) AAV2 RCs were visualized with a primary antibody 804 
specific for the AAV2 Rep proteins and an AF405-labled secondary antibody (blue). Scale 805 
bars = 10 µm. Arrowheads in A and B indicate cells positive for HSV-1 or AAV2 RCs and 806 
either the red fluorescent G1 marker Cdt1 (I) or the green fluorescent S/G2 marker geminin 807 
(II). (C) From the cultures shown in A and B, approximately 30 cells containing HSV-1 or 808 
AAV2 RCs (blue) were analyzed for their cell cycle phase (G1, early S, S/G2). The graphs 809 
show mean values from six independent experiments; error bars indicate standard 810 
deviations of the mean. 811 
FIG 2 Co-detection of cell cycle phase and AAV2 genomes. HeLa Fucci cells were mock-812 
infected, infected with wtAAV2 alone (MOI 4000), or co-infected with wtAAV2 (MOI 4000) 813 
and wtHSV-1 (MOI 3). After 24 h, the cells were fixed and processed for fluorescence in situ 814 
hybridization (FISH) and CLSM. (A) AAV2 DNA (yellow) was detected with an AF-647 815 
labeled probe as described in Methods. The red and green signals indicate cells in G1 816 
(Cdt1) and S/G2 (geminin) phases, respectively. The orange cells observed in some cultures 817 
are in early S phase where they express both Cdt1 and geminin. Areas in the box were 818 
enlarged (last column). Scale bars = 10 µm. (B) From the wtAAV2 and wtHSV-1 co-infected 819 
cultures shown in A, approximately 30 cells containing AAV2 RCs were analyzed for their 820 
cell cycle phase (G1, early S, S/G2). The graph shows mean values from six independent 821 
experiments; error bars indicate standard deviations of the mean. 822 
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FIG 3 Viral DNA replication in different phases of the cell cycle. HeLa Fucci cells were mock-823 
infected, infected with either wtAAV2 (MOI 8000) or wtHSV-1 (MOI 3), or co-infected with 824 
wtAAV2 (MOI 8000) and wtHSV-1 (MOI 3). After 24 h, cells positive for Cdt1 (G1, red) or 825 
geminin (S/G2, green) were sorted by FACS and subjected to Southern and Western blot 826 
analysis. (A) Southern blot analysis for detection of HSV-1 and AAV2 DNA (equal cell 827 
equivalents were loaded in the different lanes; ss=single stranded, rfm=replication form 828 
monomer, rfd=replication form dimer). (B) Western blot analysis to control for virus infection 829 
(HSV-1 ICP0 and AAV2 Rep; actin was used as a loading control), and (C and D) qPCR to 830 
quantify viral DNA. Graphs in C and D show mean values of relative HSV-1 or AAV2 DNA 831 
quantities from triplicate experiments; error bars indicate standard deviations of the mean. 832 
FIG 4 Co-detection of AAV2 genomes, HSV-1 RCs, and cell cycle phase. HeLa Fucci cells 833 
were co-infected with wtAAV2 (MOI 4000) and rHSV-1vECFP-ICP4 (MOI 3). After 24 h, the 834 
cells were fixed and processed for fluorescence in situ hybridization (FISH) and CLSM. (A) 835 
AAV2 DNA (yellow) was detected with an AF-647 labeled probe as described in Methods. 836 
HSV-1 RCs were detected by the binding of the HSV-1 ECFP-ICP4 fusion protein to the 837 
HSV-1 DNA (blue). The red and green signals indicate cells in G1 (Cdt1) and S/G2 838 
(geminin) phases, respectively. The area in the box (upper row, merge) was enlarged in the 839 
second row and in panel B. Scale bars = 20 µm. (B) The enlargement and sectioning of the 840 
HSV-1 RC-positive cell shown in A (box in top row) reveals the subcellular localization of 841 
AAV2 genomes (red arrows); for clarity, the red and green channels were omitted. 842 
FIG 5 Cell cycle dependent AAV2 gene expression controls replication of both AAV2 and 843 
HSV-1 in co-infected cultures. (A) HeLa Fucci cells were co-infected with rAAVCFPNeo 844 
(MOI 4000) and wtHSV-1 (MOI 3). Images were acquired by automated epifluorescence 845 
microscopy using ImageXpress Micro XL (Molecular Devices) and fluorescence filters 846 
(Semrock) for ECFP (AAV2 gene expression, blue), EGFP (S/G2 phase, green) and TRITC 847 
(G1 phase, red). Scale bars = 20 µm. (B) HeLa Fucci cells were co-infected with 848 
rAAVCFPNeo (MOI 1000) and wtHSV-1 (MOI 3) and 20 h later cell cycle phase (G1, early S, 849 
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S/G2) of rAAVCFPNeo transduced cells was determined by the expression of Ctd1 (red) and 850 
geminin (green). 40’000 cells (events) per sample were counted by flow cytometry. The 851 
graph shows mean values from triplicate experiments; error bars indicate standard 852 
deviations of the mean. (C) HeLa cells were co-infected with rHSV48EYFP (MOI 3) and 853 
either rAAVCFPRep (MOI 4000) or rAAVCFPNeo (MOI 4000). After 24 h, cells were 854 
examined by using a standard fluorescence microscope; scale bars = 10 µm. (D) From the 855 
cultures shown in (C), 50 cells containing yellow fluorescent HSV-1 RCs were analyzed for 856 
the presence of AAV2 RCs in rHSV48EYFP and rAAVCFPRep co-infected cultures or 857 
ECFP-fluorescence in rHSV48EYFP and rAAVCFPNeo co-infected cultures. The graph 858 
shows mean values from triplicate experiments; error bars indicate standard deviations of 859 
the mean. 860 
FIG 6 Detection of cell cycle phase, AAV2 gene expression, and virus replication in cells 861 
transfected with circular, double-stranded rep-positive or rep-negative recombinant AAV2 862 
genomes. (A and B) HeLa Fucci cells were transfected with (A) pAAVCFPRep or (B) 863 
pAAVCFPp5 and infected with wtHSV-1 (MOI 2) 4 h later. After 24 h, cells were examined 864 
by CLSM with filters specific for Cdt1 (G1, red), geminin (S/G2, green), and ECFP (AAV2, 865 
blue). The framed areas in A and B are shown at higher magnification on the right. 866 
Arrowheads in A indicate cells positive for AAV2 RCs and either the red fluorescent G1 867 
marker Cdt1 (I) or the green fluorescent S/G2 marker geminin (II). Scale bars in A and B = 868 
40 µm (left panels), 10 µm (right panels). (C) HeLa Fucci cells were transfected with 869 
pAAVCFPRep and, 4 h later, mock-infected or infected with wtHSV-1 (MOI 2). After 24 h, 870 
extrachromosomal DNA was prepared from Cdt1 positive G1 cells (red) and geminin positive 871 
S/G2 cells (green), digested with DpnI and subjected to qPCR with primers specific for AAV2 872 
rep. (D) HeLa Fucci cells were transfected with pAAVCFPRep or pAAVCFPp5 and infected 873 
4 h later with wtHSV-1 (MOI 2). Total DNA extracted after 24 h from ECFP (AAV2) and Cdt1 874 
(G1, red) or ECFP and geminin (S/G2, green) double-positive cells was subjected to qPCR 875 
with primers specific for HSV-1 DNA. Graphs in C and D show mean values of relative DNA 876 
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 37
quantities from triplicate experiments, samples were prepared from equal numbers of cells; 877 
error bars indicate standard deviations of the mean. 878 
FIG 7 Live cell imaging of cell cycle dependent AAV2 gene expression. (A) HeLa Fucci cells 879 
were infected with scAAVCFP (MOI 3000) or rAAVCFPNeo (MOI 3000) in absence or 880 
presence  of wtHSV-1 (MOI 3) and images were acquired every 30 min from 2-20 h after 881 
infection by automated time-lapse (37° C, 5% CO2, humidified) epifluorescence microscopy 882 
using ImageXpress Micro XL (Molecular Devices) and fluorescence filters (Semrock) for 883 
ECFP (AAV2 gene expression), GFP (G2) and TRITC (G1). A total of 36 frames was 884 
acquired and the frame numbers are indicated. Overview images are shown in the left 885 
panels. Two different positions highlighted in each of the overview images (boxes 1 and 2) 886 
were enlarged and tracked over time (right panels). Arrows point to cells from the moment 887 
ECFP-fluorescence becomes visible. (B and C) HeLa Fucci cells were infected with 888 
rAAVCFPNeo (MOI 3000) or scAAVCFP (MOI 3000) in presence or absence of HSV-1 (MOI 889 
3), images were acquired as described above, and AAV2 transgene (ECFP) positive cells 890 
were tracked over time. The graph in C shows the percentage of cells that turned ECFP 891 
positive either in G1 or in S/G2 phases.  The graph in D shows the percentage of transgene 892 
positive S/G2 cells progressing to G1 phase. Both graphs show mean values from at least 893 
100 ECFP positive cells tracked on at least 9 different infection and acquisition experiments; 894 
error bars indicate standard deviations of the mean. 895 
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TABLE 1 Cell cycle phases of AAV2 transduced cells. 
 
Cell line Infectiond G1 (%) S (%) S/G2 (%) G2 (%) 
HeLa Fuccia rAAVCFPRep 19  81  
AT22b rAAVYFPRep 16 40  44 
HCT116c rAAVYFPRep 20 33  47 
NHFb rAAVCFPRep 17 35  48 
Cell cycle phases were determined by flow cytometry with afluorescent ubiquitination- 
based cell cycle indicators (Fucci), bpropidium iodide, or cDAPI. dCo-infected with HSV-1. 
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TABLE 2 AAV2 and HSV-1 DNA replication in different cell cycle phases. 
Virus infection G1 S/G2 Illustration 
HSV-1 ++++ ++++ Figs. 1+3 
AAV2 - - Figs. 2+3 
 
AAV2 (HSV-1 co-infection) 
HSV-1 (AAV2 co-infection) 
+ 
++++ 
++++ 
+ 
Figs. 1-3, Movie S1 
Figs. 3+4 
++++, efficient DNA replication; +, inefficient DNA replication; -, no DNA replication; 
AAV2 rep expression from p5 promoter. 
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TABLE 3 Cell cycle dependent gene expression from AAV2 vectors and G2-M-G1 transition. 
AAV2 vector Gene expression in G2-M-G1 Illustration 
  G1 S/G2 transition  
ssAAV2cmv + ++++ + Fig. 7, Movie S3
ssAAV2cmv (HSV-1 co-infection) + ++++ + Figs. 5+7 
ssAAV2p5 + ++++ nd Table 1 
dsAAV2cmv + ++++ ++++ Fig. 7, Movie S2
dsAAV2cmv (HSV-1 co-infection) + ++++ + Fig. 7 
ss, single-stranded; ds, double-stranded; cmv, cytomegalovirus IE1 enhancer/promoter; p5, AAV2 p5 promoter; 
++++, efficient gene expression/G2-M-G1 transition; +, inefficient replication/G2-M-G1 transition; nd, not done. 
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